(Bloomberg)– Johnson & &Johnson, among the many final United States enterprise with main credit score report scores, goes to menace of shedding its AAA high quality from S&P Global Ratings after the producer of medicines and scientific instruments said it was acquiring Intra-Cellular Therapies Inc
Most Read from Bloomberg
S&P said on Tuesday that it’s inspecting whether or not it wants to scale back the agency’s credit score report scores, partially for the reason that $14.6 billion procurement would definitely enhance J&J’s debt. J&J will probably make much more debt-funded purchases sooner or later, in accordance with S&P.
A downgrade for J&J would definitely leaveMicrosoft Corp as the one United States agency ranked AAA. Seven firms internationally– consisting of banks– have an AAA rating from S&P, in accordance with an agent with the scores agency. That’s under 16 a years again and 88 in 2005. The present itemizing consists of Temasek Holdings, Public Sector Pension Investment Board and Airservices Australia.
Ratings declines can enhance a enterprise’s loaning costs, though with regards to enterprise within the highest doable scores charges, any type of distinction could be little or no.
On Monday, J&J said that it’s moneying the Intra-Cellular Therapies acquisition with cash and monetary debt. It anticipates to close on the discount this 12 months.
Separately, Moody’s Ratings on Tuesday verified J&J’s present AAA rating. Johnson & & Johnson has “cash-on-hand of over $20 billion as well as very strong annual free cash-flow generation,” in accordance with the bond-grading firm.
–With assist from Ethan M Steinberg.
(Updates to incorporate context on number of enterprise ranked AAA by S&P within the third paragraph.)
Most Read from Bloomberg Businessweek
© 2025 Bloomberg L.P.
